Carotid plaques in transient ischemic attack and stroke patients: One-year follow-up study by magnetic resonance imaging

Investigative Radiology

Volumn 45, Issue 12, 2010, Pages 803-809

  Kwee, Robert M ^a,b   Van Oostenbrugge, Robert J ^a,b   Mess, Werner H ^a   Prins, Martin H ^a   Van Der Geest, Rob J ^c   Ter Berg, Johannes W M ^d   Franke, Cees L ^d   Korten, Arthur G G C ^e   Meems, Bé J ^f   Van Engelshoven, Jos M A ^a,b   Wildberger, Joachim E ^a,b   Kooi, Marianne Eline ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

^f VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Carotid atherosclerosis; Magnetic resonance imaging; Plaque progression; Stroke; TIA

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; DIPYRIDAMOLE; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT COMPLIANCE; PRIORITY JOURNAL; REPRODUCIBILITY; STROKE; TRANSIENT ISCHEMIC ATTACK; WHOLE BODY MRI;

EID: 78650679602     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181ed15ff     Document Type: Article

References (36)

1. Chaturvedi S, Bruno A, Feasby T, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65:794-801.
2. Rothwell PM, Eliasziw M, Gutnikov SA, et al; Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361:107-116.
3. Takaya N, Yuan C, Chu B, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation. 2005;111:2768-2775.
4. Saam T, Yuan C, Chu B, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007;19:34-42.
5. Boussel L, Arora S, Rapp J, et al; MAPP Investigators. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging--multicenter trial. Radiology. 2009;252:789-796.
6. Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology. 2006;240:464-472.
7. U-King-Im JM, Tang TY, Patterson A, et al. Characterisation of carotid atheroma in symptomatic and asymptomatic patients using high resolution MRI. J Neurol Neurosurg Psychiatry. 2008;79:905-912.
8. Cappendijk VC, Kessels AG, Heeneman S, et al. Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: initial results. J Magn Reson Imaging. 2008;27:1356-1361.
9. Kwee RM, van Oostenbrugge RJ, Prins MH, et al. Symptomatic patients with mild and moderate carotid stenosis. plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke. 2010;41:1389-1393.
10. Available at: http://www.mrisafety.com. Accessed May 15, 2010.
11. Kwee RM, Teule GJ, van Oostenbrugge RJ, et al. Multimodality imaging of carotid artery plaques. 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging. Stroke. 2009;40:3718-3724.
12. Cappendijk VC, Cleutjens KB, Heeneman S, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging. 2004;20:105-110.
13. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005; 25:234-239.
14. Cappendijk VC, Heeneman S, Kessels AG, et al. Comparison of singlesequence T1w TFE MRI with multisequence MRI for the quantification of lipid-rich necrotic core in atherosclerotic plaque. J Magn Reson Imaging. 2008;27:1347-1355.
15. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation. 2005;112:3437-3444.
16. Kwee RM, van Engelshoven JM, Mess WH, et al. Reproducibility of fibrous cap status assessment of carotid artery plaques by contrast-enhanced MRI. Stroke. 2009;40:3017-3021.
17. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. J AMA. 2004;292:1845-1852.
18. Redgrave JN, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation. 2006;113:2320-2328.
19. Zhao X, Underhill HR, Yuan C, et al. Minimization of MR contrast weightings for the comprehensive evaluation of carotid atherosclerotic disease. Invest Radiol. 2010;45:36-41.
20. Landry A, Spence JD, Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke. 2004;35:864-869.
21. Burke AP, Kolodgie FD, Farb A, et al. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002;105:297-303.
22. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation. 2002;105:939-943.
23. Takeuchi H, Morino Y, Matsukage T, et al. Impact of vascular remodeling on the coronary plaque compositions: an investigation with in vivo tissue characterization using integrated backscatter-intravascular ultrasound. Atherosclerosis. 2009;202:476-482.
24. Peeters W, Hellings WE, de Kleijn DP, et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol. 2009;29:128-133.
25. Moody AR, Murphy RE, Morgan PS, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation. 2003;107:3047-3052.
26. Anzalone N, Scomazzoni F, Cirillo M, et al. Follow-up of coiled cerebral aneurysms at 3T: comparison of 3D time-of-flight MR angiography and contrast-enhanced MR angiography. Am J Neuroradiol. 2008;29:1530-1536.
27. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054-2061.
28. Kwee RM, Schreuder FH, Mess WH, et al. Images in cardiovascular medicine: development of carotid intraplaque hemorrhage demonstrated by serial magnetic resonance imaging. Circulation. 2009;120:1637-1639.
29. Ueda Y, Asakura M, Yamaguchi O, et al. The healing process of infarctrelated plaques. Insights from 18 months of serial angioscopic follow-up. J Am Coll Cardiol. 2001;38:1916-1922.
30. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005;46:106-112.
31. Redgrave JN, Gallagher P, Lovett JK, et al. Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke. 2008;39: 1722-1729.
32. Kerwin WS, O'Brien KD, Ferguson MS, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology. 2006;241:459-468.
33. Lobbes MB, Heeneman S, Passos VL, et al. Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-ofconcept study. Invest Radiol. 2010;45:275-281.
34. Alsaid H, De Souza G, Bourdillon MC, et al. Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study. Invest Radiol. 2009;44:151-158.
35. Lohan DG, Tomasian A, Saleh RS, et al. Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 Tesla. Invest Radiol. 2009;44:207-217.
36. Anzidei M, Napoli A, Marincola BC, et al. High-resolution steady state magnetic resonance angiography of the carotid arteries: are intravascular agents necessary? Feasibility and preliminary experience with gadobenate dimeglumine. Invest Radiol. 2009;44:784-792.